Recent years have brought revolutionary innovations in lung cancer treatment. A group of biological drugs called checkpoint inhibitors—monoclonal antibodies—or IMMUNOTHERAPY, have become an important part of lung cancer treatment. These drugs activate the immune system's fighting cells (T lymphocytes) to attack the tumor. These drugs either bind to the PD-1 receptor on T lymphocytes (Anti-PD-1 blockers)
Cancer is a disease that has existed since the dawn of humanity. The first steps in modern cancer treatment were taken after World War II. The successful use of drugs in cancer treatment began in the 1970s. The treatment of cancer with drugs is called chemotherapy, and these drugs are called chemotherapy drugs. The most important reason for using drug therapy in cancer treatment is that cancer is generally a systemic disease (i.e., it affects many parts of the body).
Cancer has existed on Earth since the dawn of humanity. With the increase in human lifespan and the decrease in deaths from infectious diseases, cancer became one of the most common diseases of the 20th century. The decline in deaths from heart and vascular diseases over the past decade and the fact that they will be less common in the future will make cancer the most important disease of the 21st century. Cancer occurs when a cell in our body, one day, for no apparent reason,
Breast cancer is the most common type of cancer in women. In developed countries, one in every 7-8 women who live to the age of 70 will develop breast cancer. Although the exact figures are unknown in our country, it is an inevitable fact that the incidence of breast cancer will increase due to increasing industrialization and changing dietary habits. Three-quarters of women diagnosed with breast cancer have no specific risk factors other than being female.
Lung cancer has gone down in world history as one of the most significant diseases of the 20th century. Both statistically and biologically, it has been proven that smoking is the most important cause of this disease. Following trends toward smoking cessation in Western countries, a decline in the incidence of lung cancer cases has emerged, at least among men. Among women, deaths from lung cancer have surpassed those from breast cancer in number. Last year
What do you think about the link between cancer and nutrition? What do you think we absolutely must do and absolutely must not do to avoid getting cancer? "Eat this and you won't get cancer, or don't eat that and you will get cancer!" After all these years, I think: there's no such thing! What about smoking? No, of course not, the harm of smoking is very obvious. I always say, from the moment it enters your body, it affects everything.
Bağışıklık sisteminin, eskiden, kanserde çok önemli olmadığını düşünürdük, bir iki kanser türü dışında. Şimdi anlıyoruz ki, öyle değil. Kanserle savaşan asker hücrelerimiz, T hücreleri, yani T lenfositleri, üzüntü ve büyük stres altında çok iyi hareket edemiyor, tembelleşip aptallaşıyorlar. Aslında vücudumuzda her gün, kanser hücreleri oluşuyor ama bizim T lenfositlerimiz onları tanıyor, “Gel buraya edepsiz!” deyip
The side effects are minimal and manageable, but whether immunotherapy (immuno-oncology) drugs, which are effective against many types of cancer, will replace chemotherapy and other treatments remains to be seen. While initial studies suggest these drugs are "revolutionary," there are some problematic areas. The main issue is that the drugs do not work for all patients. The place of immunotherapy drugs in treatment in the near future is still unclear.
Kanser Uzmanı Dr. Süalp Tansan’a göre en tehlikeli kanser melanom güneş ışınları yüzünden. Solaryum da en güneş kadar tehlikelidir diyen Tansan, en 30 koruma faktörü öneriyor. Kanser Uzmanı Dr. Süalp Tansan ile röportajımızın yayınlanan dünkü bölümünde dünyadaki kanser üzerine yapılan çalışmaları, yenilikleri özetlemiştik. Tansan’ın dünkü “Sigara içenler sakın vitamin almasınlar” açıklamasından sonra gazetenin telefonları kilitlendi.
I turned my phone around. "I hope I never end up as your patient, but if I get cancer, I'll come to you," I said. "Who am I speaking to?" he asked. I introduced myself, thinking he'd say "Oh," but he didn't even acknowledge me, even looking for an opportunity to hang up. Finally, he politely said he didn't want to give an interview. Well, I have to bring you a job every week too! One
- 1
- 2